✦ LIBER ✦

5.56 Ofatumumab in Combination with High-Dose Methylprednisolone as a Salvage Treatment for Heavily Pretreated or Refractory Patients with Chronic Lymphocytic Leukemia

✍ Scribed by Juan S. Barajas-Gamboa; Julio A. Diaz-Perez; Lina M. Ariza-Serrano; John M. Horton; Danelle F. James; Amine Ale-Ali; Thomas J. Kipps; Januario E. Castro

Book ID: 119219000
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 68 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Local experience with the novel human an

Local experience with the novel human anti-CD20 antibody, ofatumumab, as salvage treatment for patients with heavily pretreated chronic lymphocytic leukaemia

✍ C. Y. Cheah; D. A. Carney; S. M. Lim; H. Januszewicz; J. Scarlett; J. F. Seymour 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 763 KB

Rituximab in combination with high-dose

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia

✍ Castro, J E; Sandoval-Sus, J D; Bole, J; Rassenti, L; Kipps, T J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

Bortezomib Followed by a Phase I Study o

Bortezomib Followed by a Phase I Study of Bortezomib in Combination With High-Dose Melphalan as a Preparative Regimen for Hematopoietic Cell Transplants in Patients With Primary Refractory Multiple Myeloma or Plasma Cell Leukemia

✍ T. Nishihori; T.J. Alekshun; D.M. Sullivan; M.A. Kharfan-Dabaja; J. Raychaudhuri 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 86 KB